483 GlaxoSmithKline Biologicals SA Jun 2019

483 GlaxoSmithKline Biologicals SA Jun 2019

$119 - Not in Stock

FDA investigators audited the GlaxoSmithKline Biologicals SA - Rixensart, Belgium facility and issued inspectional observations (via FDA 483) on 24 Jun 2019.

Product details

  • Category: Biologics
  • Inspection end: 24 Jun 2019
  • Location: Rixensart, Belgium
  • FEI: 3002875226

Pre-Order Not Available